ID, age (y), sex | Initial inoculation trial | Reinoculation trial | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Time (weeks) | Time (weeks) | |||||||||
0–4 | 5–8 | 9–12 | 13–16 | 17–20 | 27 | 30 | 35 | 39–41 | 45 | |
L3i, n 3rd stage N americanus larvae inoculated percutaneously; P, prednisone n mg/day; A, azathioprine n mg/day; M, methotrexate n mg/week. | ||||||||||
CD1 55 M | ||||||||||
Inoculum therapy | 25 L3i | 25 L3i | ||||||||
CDAI | 79 | 60 | 89 | 77 | 68 | 96 | 93 | 62 | ||
CD2 46 M | ||||||||||
Inoculum therapy | 25 L3i | 25 L3i | ||||||||
CDAI | 38 | 114 | 20 | 68 | 48 | 30 | 36 | |||
CD3 41 F | ||||||||||
Inoculum therapy | 25 L3i P5 M15 | P5 M15 | P5 M7.5 | 25 L3i P5 M10 | P5 M10 | P5 M10 | M10 | M10 | ||
CDAI | 46 | 71 | 85 | 83 | 90 | 36 | 30 | 92 | 95 | |
CD4 34 M | ||||||||||
Inoculum therapy | 50 L3i P38 M30 | P38 M30 | P50 M30 | P25 M30 | P5 M30 | 50 L3i P5 M20 | P2.5 M20 | M20 | P25 M30 | P20 M30 |
CDAI | 260 | 230 | 232 | 264 | 118 | 60 | 442 | 60 | 122 | |
CD5 21 F | ||||||||||
Inoculum therapy | 50 L3i P10 M20 | P10 M20 | P13 M20 | P10 | P7.5 | P5 | 25 L3i P5 | P25 M20 | P15 M20 | P10 M20 |
CDAI | 144 | 151 | 103 | 79 | 73 | 410 | 180 | 44 | 61 | |
CD6 33 F | ||||||||||
Inoculum therapy | 50 L3i P15 M20 | P10 M20 | P5 M20 | P5 M20 | P7.5 M20 | |||||
CDAI | 49 | 32 | 6 | 29 | 100 | |||||
CD7 33 M | ||||||||||
Inoculum therapy | 50 L3i A150 | P25 A150 | P5 A150 | P5 A150 | P8 A150 | |||||
CDAI | 260 | 114 | 96 | 125 | 118 | |||||
CD8 46 M | ||||||||||
Inoculum therapy | 50 L3i M20 | M20 | M20 | M20 | M20 | |||||
CDAI | 145 | 159 | 171 | 152 | 186 | |||||
CD9 44 F | ||||||||||
Inoculum therapy | 100 L3i P5 M20 | P10 M20 | P5 M20 | P5 M20 | P10 M20 | |||||
CDAI | 173 | 127 | 106 | 76 | 125 |